The belief that stem cells could potentially be used to treat numerous diseases in the future stems from the past achievements in using adult stem cells obtained from bone marrow to successfully treat patients suffering from leukemia, cancer, and hereditary blood disorders. However, there is a range of different types of stem cells that can be categorized based on their ability to differentiate into various cell types. The three categories of stem cells that hold the most relevance for their potential use in regenerative medicine are pluripotent, multipotent, and unipotent stem cells.
In the area of women’s health, different types of stem cells with multiple abilities have been used in research methods. Recently, thorough evaluations have thoroughly examined the possibility of utilizing stem cells for the purpose of addressing infertility. To be more precise, the possibility of restoring and producing egg cells in the ovaries of women using a small group of cells found in the ovaries or pluripotent stem cells is full of promise and generates enthusiasm. Nevertheless, the effectiveness of cell derivation and differentiation procedures is lacking, and the extensive manipulation in the laboratory leads to significant epigenetic and genetic alterations. Additionally, ethical and regulatory limitations pose considerable obstacles, intensifying the ongoing discussion regarding the feasibility of applying these studies in a clinical setting. However, the concept of creating innovative in vitro models or mimics of the female reproductive tract using human ES and iPS cells, with the aim of comprehending the specific molecular causes of infertility and developing novel treatment approaches, is extremely thrilling.